Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

✍ Scribed by Takahashi, F; Chiba, N; Tajima, K; Hayashida, T; Shimada, T; Takahashi, M; Moriyama, H; Brachtel, E; Edelman, E J; Ramaswamy, S

• Book ID: 109972876
• Publisher: Nature Publishing Group
• Year: 2011
• Tongue: English
• Weight: 899 KB
• Volume: 30
• Category: Article
• ISSN: 0950-9232
• DOI: 10.1038/onc.2011.24